Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-010487

CHIEF OPERATING OFFICER gave up 801 shares (to pay taxes)

  • CHIEF OPERATING OFFICER acquired 2,726 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tessari Eben CHIEF OPERATING OFFICER 2025-04-07 Option exercise +2,726 83,164 D
Tessari Eben CHIEF OPERATING OFFICER 2025-04-07 Shares withheld for taxes −801 $20.28 $16,244 82,363 D
Derivatives
Tessari Eben CHIEF OPERATING OFFICER 2025-04-07 Option exercise · Restricted Share Unit −2,726 2,726 D
Loading xslF345X05/form4-04092025_080449.xml…